Access To Care Survey
EU market research developed with KPMG.
Summary
ABOUT THE ACCESS TO CARE SURVEY
The EMHA worked along KPMG on a market research to understand the patient journey and burden of disease for migraine in 12 countries. The Access to care survey 2021 has shown insightful results on the patients’ access to treatment and care in each of their country.
Migraine in the EU: Lifting the barriers to treatment
The European Migraine & Headache Alliance (EMHA) organised a webinar “Migraine in the EU: Lifting the barriers to treatment” to present the results of a survey looking into the migraine patients’ journey to have a diagnosis and treatment for their disease in the European Union (EU). The survey was conducted in 2021, with close to 3,400 participants from 10 countries.
The webinar of 29 September 2021 was hosted by Deirdre Clune, Member of the European Parliament (Ireland) and member of the European Parliament Migraine Alliance.
Highlights by country
FINLAND
Download the whole study to learn more on the Access to Care Survey findings in Finland.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (163 from Finland)
FRANCE
Download the whole study to learn more on the Access to Care Survey findings in France.
Since the launch of the survey in March 2020, we have reached a total number of 3,397 answers (296 from France).
GERMANY
Download the whole study to learn more on the Access to Care Survey findings in Germany.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (601 from Germany)
GREECE
Download the whole study to learn more on the Access to Care Survey findings in Greece.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (324 from Greece)
IRELAND
Download the whole study to learn more on the Access to Care Survey findings in Ireland.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (237 from Ireland)
ITALY
Download the whole study to learn more on the Access to Care Survey findings in Italy.
From the 3397 answered surveys completed by migraine patients from 41 different countries (See question 1.1). 12% of the responses corresponded to Italian migraine patients.
LATVIA
Download the whole study to learn more on the Access to Care Survey findings in Latvia.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (268 from Latvia)
NORWAY
Download the whole study to learn more on the Access to Care Survey findings in Norway.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (201 from Norway)
UK
Download the whole study to learn more on the Access to Care Survey findings in the UK.
“Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (238 from UK)
SPAIN
Download the whole study to learn more on the Access to Care Survey findings in Spain.
Access to Care III” survey consisted on 39 items distributed in 4 dimensions and reached 3,397 total answers (439 from Spain)
GET IMPATIENT FOR MIGRAINE
The Impatient Chair campaign has evolved to promote and raise awareness about the results of the Italian Access To care. To achieve this goal we will also work on the following communication objectives:
- To generate notoriety and awareness on migraine.
- To spread the message in the most consistent way across the different European countries that will be involved in the campaign.
- To reach the following audiences: policy makers, patients, society and the media.
